Archive

Bart Janssens, Partner & Director BCG and Rahul Guha, Principal, BCG about the areas of unique advantage for India in…

The Indian biopharma industry is concerned that if Obamacare is repealed due to the individual mandate issue, their plans for the…

With India's DBT commiting 30 per cent of its budget to PPPs, will these fund an ecosystem for small and medium sized companies…

Venus Remedies has received patent from the US Patent Office for a breakthrough antibiotic product.

PARTAKE is a non-partisan, not-for-profit initiative, the collaborative effort of all stakeholders involved in clinical research,…

BIRAC's Biotechnology Ignition Grant (BIG) scheme for igniting new ideas opened on 1st June, closes on July 15

The company is also investing in its fourth domestic unit in Rajasthan

To develop and commercialise Biosimilars

Offers slew of incentives for Indian pharma companies

Completes acquisition for approximately Rs 3,400 crores